Search for content, post, videos

Recipharm acquires GenIbet

Marc Funk
Recipharm has announced the acquisition of GenIbet, a Portuguese CDMO, specializing in the manufacture of biological clinical trial material and novel modalities such as viral vectors, RNA and microbiome. The acquisition forms part of Recipharm’s strategy to grow in the biologics market, with a
Already a subscriber Login

You have read all your free articles, to continue reading subscribe to read the rest of this content.